nhc20181115_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

___________________________

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 15, 2018 (November 15, 2018)

 

____________________________

 

NATIONAL HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

____________________________

 

 

Delaware

(State or other jurisdiction of incorporation)

001-13489

(Commission File Number)

52-2057472

(I.R.S. Employer Identification No.)

 

100 Vine Street

Murfreesboro, Tennessee

(Address of Principal Executive Offices)

 

 

37130

(Zip Code)

 

Registrant’s telephone number, including area code: (615) 890-2020

 

 

Not Applicable

(Former name or former address, if changed since last report)

 

__________________________________

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company       [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [  ]

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Today the Board of Directors of National HealthCare Corporation (the “Company”) announced that John K. Lines, Senior Vice President, General Counsel & Secretary, resigned November 15, 2018.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

NATIONAL HEALTHCARE CORPORATION

 

 

 

 

 

 

By:

 /s/ Stephen F. Flatt

 

 

Name:

 Stephen F. Flatt

 

 

Title:

 Chief Executive Officer

 

Date:     November 15, 2018